The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.

This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.

Reporting on 2009 surveillance data and 2010 epidemic intelligence data

This report presents the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.

This ECDC Communicable Disease Threats Report covers 18-24 December 2016 and includes updates on Salmonella Stourbridge, type E botulism, hepatitis A, tuberculosis, cholera, influenza, measles, rubella, Legionnaires' disease and the Zika virus.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2–8 April 2017 and includes updates on influenza, MDR TB and Measles.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 April 2017 and includes updates on hepatitis A, influenza, MDR TB, measles, yellow fever, Zika, dengue and Chikungunya.